These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prevalence and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Southern China. Pang Y; Zhu D; Zheng H; Shen J; Hu Y; Liu J; Zhao Y BMC Infect Dis; 2017 Nov; 17(1):711. PubMed ID: 29110640 [TBL] [Abstract][Full Text] [Related]
4. Phenotypic and molecular characterization of pyrazinamide resistance among multidrug-resistant Mycobacterium tuberculosis isolates in Ningbo, China. Che Y; Bo D; Lin X; Chen T; He T; Lin Y BMC Infect Dis; 2021 Jun; 21(1):605. PubMed ID: 34171989 [TBL] [Abstract][Full Text] [Related]
5. Value of pyrazinamide for composition of new treatment regimens for multidrug-resistant Mycobacterium tuberculosis in China. Xia H; van den Hof S; Cobelens F; Zhou Y; Zhao B; Wang S; Zhao Y BMC Infect Dis; 2020 Jan; 20(1):19. PubMed ID: 31910878 [TBL] [Abstract][Full Text] [Related]
6. Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia. Sengstake S; Bergval IL; Schuitema AR; de Beer JL; Phelan J; de Zwaan R; Clark TG; van Soolingen D; Anthony RM BMC Infect Dis; 2017 Jul; 17(1):491. PubMed ID: 28697808 [TBL] [Abstract][Full Text] [Related]
7. Multicenter Study of the Emergence and Genetic Characteristics of Pyrazinamide-Resistant Tuberculosis in China. Li D; Hu Y; Werngren J; Mansjö M; Zheng X; Drobniewski F; Hoffner S; Xu B Antimicrob Agents Chemother; 2016 Sep; 60(9):5159-66. PubMed ID: 27297481 [TBL] [Abstract][Full Text] [Related]
8. Surveillance of pyrazinamide susceptibility among multidrug-resistant Mycobacterium tuberculosis isolates from Siriraj Hospital, Thailand. Jonmalung J; Prammananan T; Leechawengwongs M; Chaiprasert A BMC Microbiol; 2010 Aug; 10():223. PubMed ID: 20727143 [TBL] [Abstract][Full Text] [Related]
10. [Prevalence and transmission of pyrazinamide-resistant Liu BB; Hu PL; Chen ZH; Yi SL; Zhang XP; Tan YH Zhonghua Jie He He Hu Xi Za Zhi; 2022 Jul; 45(7):677-685. PubMed ID: 35768376 [No Abstract] [Full Text] [Related]
11. Genotypic characterization of pyrazinamide resistance in Mycobacterium tuberculosis isolated from Lusaka, Zambia. Bwalya P; Yamaguchi T; Mulundu G; Nakajima C; Mbulo G; Solo ES; Fukushima Y; Kasakwa K; Suzuki Y Tuberculosis (Edinb); 2018 Mar; 109():117-122. PubMed ID: 29559115 [TBL] [Abstract][Full Text] [Related]
12. Genetic surveillance and outcomes of pyrazinamide and fluoroquinolones-resistant tuberculosis in Taiwan. Huang HT; Lin WH; Chan TH; Jou R J Microbiol Immunol Infect; 2023 Dec; 56(6):1236-1244. PubMed ID: 37690869 [TBL] [Abstract][Full Text] [Related]
13. Rapid diagnosis of pyrazinamide-resistant multidrug-resistant tuberculosis using a molecular-based diagnostic algorithm. Simons SO; van der Laan T; Mulder A; van Ingen J; Rigouts L; Dekhuijzen PN; Boeree MJ; van Soolingen D Clin Microbiol Infect; 2014 Oct; 20(10):1015-20. PubMed ID: 24890253 [TBL] [Abstract][Full Text] [Related]
14. Direct Detection of Pyrazinamide Resistance in Mycobacterium tuberculosis by Use of Tam KK; Leung KS; Siu GK; Chang KC; Wong SS; Ho PL; Leung EK; Yam WC J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31189582 [TBL] [Abstract][Full Text] [Related]
15. Pyrazinamide susceptibility testing of Mycobacterium tuberculosis by high resolution melt analysis. Pholwat S; Stroup S; Gratz J; Trangan V; Foongladda S; Kumburu H; Juma SP; Kibiki G; Houpt E Tuberculosis (Edinb); 2014 Jan; 94(1):20-5. PubMed ID: 24246607 [TBL] [Abstract][Full Text] [Related]